VYGR

Companies
NASDAQ
Voyager Therapeutics Inc.
Health Care
Price Chart
Overview

About VYGR

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Market Cap
$458.0M
Volume
1.2M
Avg. Volume
1.1M
P/E Ratio
-1.9642857
Dividend Yield
0.00%
Employees
155.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
1.46
High Correlation
Volatility
High (0.68)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for VYGR.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, VYGR shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$458.0M
Volume1.2M
P/E Ratio-1.96
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
August 4, 2025

PortfolioPilot Analysis

Get AI-powered insights on how VYGR fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025